Roche raises earnings forecast after strong revenue growth

The Swiss pharmaceutical company Roche (i) raised its earnings forecast for the full year on October 22, 2025, after reporting a 7% increase in group revenue at constant exchange rates to CHF 45.9 billion for the first nine months of 2025. In Swiss francs, revenue increased by 2%. The Basel-based healthcare company now expects core earnings per share at constant exchange rates to grow in the high single to low double digits and is also planning an increase in the dividend in Swiss francs. "We continue to build on our positive momentum with strong...